TABLE 1.
Pharmacological inhibitors used in this work
| Inhibitor | Effect | Concn |
|---|---|---|
| EIPA | Inhibits Na+/H+ exchange | 100 μM |
| Chlorpromazine | Inhibits clathrin-dependent endocytosis | 25 μΜ |
| Methyl-β-cyclodextrin | Extracts cholesterol from lipid membranes | 1 mM |
| Nocodazole | Depolymerizes microtubules | 33.2 μΜ |
| Cytochalasin D | Disrupts actin polymerization | 5 μg/ml |
| Latrunculin A | Disrupts actin polymerization | 1 μM |
| Jasplakinolide | Stabilizes actin microfilaments | 2 μM |
| Wortmannin | Inhibits phosphoinositide-3-kinase | 100 nM |
| Nystatin + progesterone | Disrupts caveolae/lipid rafts | 25 μg/ml + 10 μg/ml |